Alpharma, LLC Sustainability Profile
Alpharma, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a strong operational presence across North America and Europe, Alpharma focuses on delivering innovative solutions in pain management, anti-infectives, and controlled substances. The company is renowned for its commitment to quality and compliance, ensuring that its products meet rigorous industry standards. Notable achievements include a robust portfolio of FDA-approved medications that cater to diverse therapeutic areas. Alpharma's dedication to research and development, coupled with its strategic partnerships, positions it as a trusted name in the pharmaceutical landscape, continually striving to enhance patient care and accessibility.
DitchCarbon Score
How does Alpharma, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alpharma, LLC's score of 45 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alpharma, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Zoetis Inc., which may influence its climate commitments and reporting practices. While Alpharma has not set explicit reduction targets or initiatives, it is part of a corporate family that includes Zoetis Inc., which has its own sustainability strategies. The emissions data and climate performance metrics from Zoetis Inc. may provide insights into the broader environmental goals that could impact Alpharma's operations. As of now, Alpharma's climate commitments remain unspecified, and there are no documented initiatives or targets related to carbon emissions reduction. The company may benefit from the sustainability frameworks and practices established by its parent organisation, Zoetis Inc., particularly in areas such as renewable energy and emissions management.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 73,391,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 193,434,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is Alpharma, LLC's Industry?
How Carbon Intensive is Alpharma, LLC's Location?
Alpharma, LLC's Scope 3 Categories Breakdown
Alpharma, LLC's Scope 3 emissions, which increased by 10% last year and decreased by approximately 8% since 2021, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 23% of total emissions under the GHG Protocol, with "Business Travel" being the largest emissions source at 64% of Scope 3 emissions.
Top Scope 3 Categories
Alpharma, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alpharma, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
